Lizzy Quinn is a Musculoskeletal Physiotherapist with 20 years experience focusing on people with spinal pain. Australian Health Journal spoke with Lizzy on the complexities of persistent lower back pain in women.
Lower back pain in women in their 30s, 40s, and 50s is complex to treat due to the combination of physical and emotional factors, and health professionals need to stay updated on best practices and science to provide the best recovery platform for patients. These women typically have busy lives, pressures, and expectations.
The Australian Institute of Health and Welfare (AIHW) website states, ‘Mental and behavioural conditions commonly co-occur with musculoskeletal conditions. Compared with people without musculoskeletal conditions, for people aged 45 and over with mental and behavioural conditions were 1.9 times as likely in people with back problems, 1.6 times as likely in people with arthritis and 1.5 times as likely in people with osteoporosis’.
Lizzy believes women with persistent lower back pain need treatment that considers their emotional and physical pain due to the complexity of their lives. Women with lower back pain often try various treatments without realising the impact of their emotional state on their symptoms, making long-term recovery difficult.
Changes in the spine as we age are normal, but the language used in MRI reports can make it concerning for patients, without a healthcare professional providing a through explanation of some of the terms.
Lizzy states, “MRI findings generally provide little information on how to recover from lower back pain, and only a small number of people actually need imaging straight away. For the majority, it won’t change their treatment.”
Getting a lower back MRI may lead to unnecessary worry as normal age-related changes are often misinterpreted as serious issues.
As far as the body is concerned, the brain cannot tell the difference between physical pain and emotional pain, making lower back pain complex to treat.
Lower back pain may be driven by tissue sensitivity and hyper-sensitisation in the brain, rather than just joint issues.
Emotional distress can reactivate sensitisation in the brain, that can cause persistent lower back pain, especially when combined with emotional distress. Sensitised pain centres in the brain, can prolong lower back pain even after physical healing.
Educating patients about the complexity of lower back pain is important, but GPs have limited time to do so, making it challenging for them to convey the message to their clients.
Without this awareness, patients will fail to understand the main drivers of lower back pain that are vital for long term recovery.
-
Upskilling & empowering Health Professionals to support preconception to pre-school level health
A new podcast series, developed by Health and Wellbeing Queensland, is designed to upskill and empower health professionals in their support of parents from preconception through to the pre-school years.
Clinician’s Guide to the First 2000 Days follows the success of Health and Wellbeing Queensland’s first podcast series Clinician’s Guide to Healthy Kids, launched in 2023. Both focus on supporting health professionals to have effective conversations on positive health behaviours.
-
Elevating Professional Standards in the Medtech and Pharmaceutical Sector
ARCS Australia Ltd, the peak body representing professionals in the MedTech and Pharmaceutical sector, this week announced a series of significant changes at its annual conference.
Dr Tim Boyle, CEO of ARCS Australia Ltd speaking to Australian Health Journal says, “These initiatives are central to strategy to build professionalism within the sector, increase capability and enhance the professional standing of its members.”
-
Report gives insights to clinical trial activity in Australia
Established in 2024, Bellberry is a Adelaide-based national, not-for-profit organisation that provides streamlined scientific and ethical reviews of human research. It is the 2025 winner of the Championing Health Award in the Telstra Best of Business Awards.
Australian Health Journal spoke with Bellberry Limited CEO, Kylie Sproston on the organisation and the findings in activity documented in the Clinical Trial Activity Report (CTAR) 2024.
